Načítá se...
Living Donor Renal Transplantation Using Alemtuzumab Induction and Tacrolimus Monotherapy
Alemtuzumab was used as an induction agent in 205 renal transplant recipients undergoing 207 living donor renal transplants. All donor kidneys were recovered laparoscopically. Postoperatively, patients were treated with tacrolimus monotherapy, and immunosuppression was weaned when possible. Forty-se...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2006
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3154761/ https://ncbi.nlm.nih.gov/pubmed/16889606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1600-6143.2006.01495.x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|